Iron supplementation of breast-fed Honduran and Swedish infants from 4 to 9 months of age
Iron supplementation of breast-fed Honduran and Swedish infants from 4 to 9 months of age
复制标题
DOI:
10.1067/mpd.2001.112895
复制
发表时间:
2001-05-01
影响因子:
5.1
通讯作者:
Lönnerdal, B
中科院分区:
文献类型:
--
作者:
Domellöf, M;Cohen, RJ;Lönnerdal, B
Objective: The objective was to study the effects of iron supplementation on hemoglobin and iron status in 2 different populations.Study design: In a randomized, placebo-controlled, masked clinical trial, we assigned term Swedish (n = 101) and Honduran (n = 131) infants to 3 groups at 4 months of age: (1) iron supplements, 1 mg/kg/d, from 4 to 9 months, (2) placebo, 4 to 6 months and iron, 6 to 9 months, and (3) placebo, 4 to 9 months. All infants were breast-fed exclusively to 6 months and partially to 9 months.Results: From 4 to 6 months, the effect of iron (group 1 vs 2 + 3) was significant and similar in both populations for hemoglobin, ferritin, and zinc protoporphyrin. From 6 to 9 months, the effect (group 2 vs group 3) was significant and similar at both sites for all iron status variables except hemoglobin, for which there was a significant effect only in Honduras. In Honduras, the prevalence of iron deficiency anemia at 9 months was 29% in the placebo group and 9% in the supplemented groups. In Sweden, iron supplements caused no reduction in the already low prevalence of iron deficiency anemia at 9 months (